ARTLW
Income statement / Annual
Last year (2022), Artelo Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Artelo Biosciences, Inc.'s net income was -$9.87 M.
See Artelo Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
08/31/2017 |
08/31/2016 |
08/31/2015 |
08/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$4.32 M
|
$2.84 M
|
$1.92 M
|
$1.09 M
|
$1.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$5.96 M
|
$4.60 M
|
$2.77 M
|
$2.12 M
|
$1.09 M
|
$232,789.00
|
$29,690.00
|
$15,241.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.96 M
|
$4.60 M
|
$2.77 M
|
$2.12 M
|
$1.09 M
|
$232,789.00
|
$29,690.00
|
$15,241.00
|
$15,269.00
|
| Other Expenses |
$0.00 |
$0.00 |
$1,412.00 |
$31,256.00 |
$290.00 |
$3,332.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$10.29 M |
$7.44 M |
$4.69 M |
$3.21 M |
$2.34 M |
$232,789.00 |
$29,690.00 |
$15,241.00 |
$15,269.00 |
| Cost And Expenses |
$10.29 M |
$7.44 M |
$4.69 M |
$3.21 M |
$2.34 M |
$232,789.00 |
$29,690.00 |
$15,241.00 |
$15,269.00 |
| Interest Income |
$2,000.00 |
$2,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$5,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$2,100.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2,000.00
|
-$2,000.00
|
$500.00
|
$510.00
|
$282.00
|
$600.00
|
$22,816.00
|
$0.00
|
$0.00
|
| EBITDA |
-$10.29 M
|
-$7.44 M
|
-$4.71 M
|
-$4.22 M
|
-$2.34 M
|
-$232,789.00
|
-$29,690.00
|
-$15,241.00
|
-$15,269.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$204,000.00
|
$2,000.00
|
$30,913.00
|
$1.04 M
|
$0.00
|
-$2,100.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$10.08 M |
-$7.44 M |
-$4.65 M |
-$2.17 M |
-$2.34 M |
-$234,889.00 |
-$29,690.00 |
-$15,241.00 |
-$15,269.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$209,000.00 |
-$4,000.00 |
-$60,414.00 |
-$2.04 M |
$8.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$9.87 M |
-$7.44 M |
-$4.65 M |
-$2.17 M |
-$2.34 M |
-$234,889.00 |
-$29,690.00 |
-$15,241.00 |
-$15,269.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-3.49 |
-5.97 |
-18.83 |
-15 |
-27.52 |
-3.23 |
-0.47 |
-0.24 |
-0.6 |
| EPS Diluted |
-3.49 |
-5.97 |
-18.83 |
-15 |
-27.52 |
-3.23 |
-0.47 |
-0.24 |
-0.6 |
| Weighted Average Shares
Out |
$2.83 M
|
$1.25 M
|
$247,000.00
|
$144,000.00
|
$84,000.00
|
$72,000.00
|
$63,000.00
|
$63,666.00
|
$25,000.00
|
| Weighted Average Shares
Out Diluted |
$2.83 M
|
$1.25 M
|
$247,176.00
|
$144,831.00
|
$85,168.00
|
$72,770.00
|
$63,666.00
|
$63,666.00
|
$25,616.00
|
| Link |
|
|
|
|
|
|
|
|
|
